Take the first step towards a pain-free life.

Subscribe to receive news and updates.

Enter your email address
The form has been submitted successfully!
There has been some error while submitting the form. Please verify all form fields again.
Web_01.png
APTEUMSPINENEUROSURGERY & SPINE CARE
Home
Spinal cord stimulation evaluation

Still in pain despite treatment or surgery?

If back, leg, neck or arm pain still limits your life, get a careful review of your options—including whether spinal cord stimulation is appropriate.

Request an SCS Evaluation (Form)

Telehealth or in person. Your request does not confirm an appointment.

30 years of SCS experience
Dr. Louis G. Cornacchia III · Neurosurgeon
Implantation, programming and revision
Spinal cord stimulation device components
Examples of spinal cord stimulation devices.
Device selection depends on your individual evaluation.
A diagnosis before a device decision

An evaluation is a next step.
It is not a commitment to an implant.

Persistent pain can have more than one cause. We review your symptoms, imaging and previous treatment before discussing whether SCS, another treatment or further evaluation makes sense.

01 · UNDERSTAND

Review the cause of your pain

Bring available imaging, previous operative reports and a list of treatments you have tried.

02 · COMPARE

Discuss the alternatives

Understand the expected benefits, limitations and risks before choosing your next step.

03 · IF APPROPRIATE

Consider a temporary trial

A trial can help assess your response before a decision about a permanent system.

Dr. Louis G. Cornacchia III
Experience & careful judgment

Meet Dr. Cornacchia.

Louis G. Cornacchia III, M.D., FAANS, FACS

A board-certified neurosurgeon with 30 years of spinal cord stimulation experience. Your evaluation focuses on your diagnosis, prior care and goals—not on assuming a device is the answer.

Read Dr. Cornacchia’s training and experience →

How spinal cord stimulation works

Watch this explanation created by Dr. Cornacchia.

English video. Press play to watch.
Understand the treatment

What is placed—and where?

SCS uses implanted leads and a pulse generator to deliver stimulation intended to help manage selected chronic pain conditions.

Lead position, generator location, programming and device choice depend on the patient. SCS does not correct every structural problem or guarantee pain relief.

Educational illustration. Placement varies by patient.

Existing educational illustration of spinal cord stimulation placement
Questions before you decide

Clear answers. Realistic expectations.

Who may benefit from an evaluation?

Selected patients with persistent pain despite appropriate treatment, including some patients with continuing symptoms after spine surgery. Your pain pattern, diagnosis and previous care determine whether SCS deserves consideration.

Does an evaluation mean I need surgery?

No. Evaluation may lead to nonsurgical care, further diagnostic work, a different procedure or discussion of an SCS trial.

What are the risks and limitations?

Risks can include infection, bleeding, lead movement, device problems, neurological injury and inadequate pain relief. Further procedures may be needed. This is not a complete list; individual risks and alternatives require a clinical discussion.

What should I bring?

Available MRI or CT images and reports, prior operative reports, device information if applicable, medication details and your treatment history.

Full SCS evaluation, treatment pathway, research and FAQs

COORDINATED SCS CARE

One Coordinated Team—from Your SCS Trial to Long-Term Care.

Dr. Cornacchia works closely with experienced pain-management physicians throughout your treatment. Your pain-management doctor may perform the initial trial, while Dr. Cornacchia performs the permanent implantation.

01

A shared treatment plan

Your pain-management physician and neurosurgeon coordinate the trial, implant decision, and follow-up.

02

Preserve the leads when appropriate

When clinically appropriate, our techniques allow the trial leads to remain in place for connection to the permanent generator—avoiding a second lead-placement procedure.

03

Support as your needs change

If your system later needs reprogramming, generator replacement, or surgical evaluation, your neurosurgeon and pain-management physician work together to help you get the best possible benefit from your stimulator.

01 Fit

Is spinal cord stimulation the right next step for your pain?

SCS is considered for selected patients with persistent neuropathic pain when a careful workup suggests that stimulation may help function and pain control, and when other causes that need different treatment have been addressed.

Problems that may prompt an SCS evaluation

  • Persistent pain after spine surgery. Burning, shooting, or radiating nerve pain that continues after a back operation.
  • Chronic back or leg pain. Pain that continues despite appropriate nonsurgical care, when further surgery is not appropriate.
  • Painful diabetic neuropathy. Persistent burning or painful feet and legs from diabetic nerve damage despite appropriate treatment.
  • Complex regional pain syndrome (CRPS). Severe limb pain and sensitivity that need specialist assessment.

What SCS does — and does not do

SCS is designed to modulate pain signaling. It does not fix structural compression, progressive weakness, spinal instability, infection, tumor, fracture, or diabetes itself.

If imaging, neurologic examination, or symptoms suggest a problem that needs decompression, stabilization, medical treatment, or urgent evaluation, that issue comes first.

Important distinction: SCS can be part of a pain-management strategy for selected patients, but it is not a substitute for diagnosing why pain is occurring.
02 Pathway

A trial-first pathway with modern programming options.

Modern SCS systems may use different stimulation patterns, including approaches with or without a tingling sensation. Evaluation focuses on diagnosis, realistic goals, trial response, programming and follow-up.

From assessment to follow-up

Your SCS treatment pathway

A decision at each stage. A shared plan throughout.

  1. 1

    Find the pain generators

    Assess symptoms, examination, imaging and prior treatment. Identify causes that can be addressed directly before considering SCS.

  2. 2

    Neurosurgical evaluation

    Check for compression, instability or another structural problem needing specific treatment. Determine whether SCS is appropriate.

  3. 3

    Pain-management evaluation

    Review medications, rehabilitation and prior procedures. Complete any needed screening and agree on pain and activity goals.

  4. 4

    Temporary stimulation trial

    Test stimulation and measure meaningful improvement in pain and daily function before considering a permanent implant.

  5. 5

    Implant, test and program

    If the trial supports proceeding, implant the system. Perform intraoperative checks and testing suited to the device and anesthesia, then individualize programming.

  6. 6

    Postoperative care

    Check healing, review precautions and device use, adjust programming and coordinate medication management. Monitor pain relief and function over time.

If the implanted system provides no benefit

Reassess the diagnosis, device and programming. If there is still no meaningful benefit, discuss removal of the implanted leads and pulse generator with your treating team. Removal requires a planned clinical procedure.

Lead management depends on the trial technique. Temporary percutaneous trial leads are usually removed. With a planned staged approach, suitable implanted trial leads may remain in place for connection to the permanent generator when clinically appropriate. Your neurosurgeon and pain-management physician tailor the sequence, testing and follow-up to your needs.

Ready to discuss whether SCS fits your diagnosis?

Request an evaluation so Apteum can review your symptoms, records, goals and prior treatment history.

Request an SCS Evaluation (Form)
Modern waveformsTrial before permanent implantShared functional goalsDevice programmingFollow-up care
03 Evidence

What published studies can — and cannot — tell you.

Research can help frame the discussion, but study results are not a prediction of your individual outcome. Your diagnosis, prior treatment, neurologic findings, anatomy, device selection, programming and trial response matter.

Most studies define response as 50% pain relief.Some studies use different endpoints, and each result below is labeled.
Trial response guides the implant decision.A temporary trial helps determine whether permanent implantation should be considered.
Results vary by patient and device.The studies used different populations, devices and definitions of success.

These studies examined different patients, devices and definitions of success. Their percentages cannot be compared directly. Some were industry funded. Study results are not Apteum patient outcomes, and individual results vary.

View detailed published response rates, chart and citations

PUBLISHED RESPONSE RATES BY CONDITION

What does “success” mean? Most pain-response studies use at least 50% pain relief. The diabetic-neuropathy and CRPS studies below use different measures, which are labeled on each result.

Back pain without prior surgery

Nonsurgical refractory back pain: 2022 trial

80.9% vs 1.3%

At 3 months, 80.9% of patients receiving 10 kHz SCS achieved at least 50% pain relief, versus 1.3% receiving conventional medical management alone. Participants had no prior spine surgery and a spine-surgeon assessment confirming they were not surgical candidates.

Read the back-pain trial

Persistent neuropathic leg pain after back surgery

PROCESS trial, 2007

48% vs 9%

In selected patients with neuropathic leg pain after prior back surgery, 48% of patients assigned to SCS plus conventional medical management achieved at least 50% leg-pain relief at 6 months, compared with 9% assigned to conventional medical management alone.

Read the PROCESS trial

Chronic back and leg pain

DTM trial, 2021

83.7% vs 51.1%

In a randomized trial of selected patients with chronic back and leg pain, 83.7% receiving differential target multiplexed stimulation achieved at least 50% back-pain relief at 12 months, compared with 51.1% receiving traditional SCS.

Read the DTM trial

Painful diabetic neuropathy

SENZA-PDN trial, 2021

79% vs 5%

In selected patients with painful diabetic neuropathy, 79% receiving 10 kHz SCS plus conventional medical management met a composite endpoint of at least 50% pain relief without neurological deterioration at 3 months, compared with 5% receiving conventional medical management alone.

Read the SENZA-PDN trial

Complex regional pain syndrome

CRPS type I: Kemler trial, 2000

39% vs 6%

At 6 months, 39% of patients assigned to SCS plus physical therapy rated themselves “much improved,” compared with 6% assigned to physical therapy alone. This is a patient-rated overall improvement measure, not a 50% pain-relief responder rate.

View the six-month study

Benefit can diminish: the overall groups were similar at five years.

View five-year follow-up

Modern advances: nearly twice the profound-relief response in one trial

In the same 2021 DTM study, 69% of DTM patients versus 35% of traditional SCS patients achieved at least 80% back-pain relief at 12 months. This result describes one treatment, one study population, and a specific pain-relief threshold; it is not a prediction of your outcome.

DTM SCS
69%
Traditional SCS
35%

Read the DTM study behind this comparison

0%25%50%75%100%

These studies examined different patients, devices, and definitions of success. Their percentages cannot be compared directly. Some were industry funded. Study results are not Apteum patient outcomes, and individual results vary.

04 Trust

Experienced neurosurgical judgment before device decisions.

A spinal cord stimulator is a medical device decision, but it is also a diagnosis decision. Apteum’s evaluation is designed to clarify whether SCS is reasonable, whether another spine problem needs attention, and what goals should define success for you.

Neurosurgeon Louis G. Cornacchia III, MD
Read Dr. Cornacchia’s biography →

Louis G. Cornacchia III, MD

Dr. Cornacchia is a neurosurgeon with 30 years of experience placing spinal cord stimulators. He works with a community of experienced pain-management doctors and with Medtronic, Boston Scientific, and other manufacturers.

Manufacturer relationships do not imply endorsement of a specific device for every patient. Brand and system selection should be based on clinical need, anatomy, MRI considerations, programming goals, prior device history, and shared decision-making.

MedtronicBoston ScientificAdditional systems as clinically appropriate
05 Next step

Request a telehealth or in-person SCS evaluation.

If pain is still controlling your life after surgery, nonsurgical care, neuropathy treatment, or an existing stimulator problem, Apteum can help you understand whether spinal cord stimulation deserves consideration.

Prepare for your visit

For the most useful evaluation, bring or upload prior procedure history, recent imaging reports or discs, a medication list, and the make/model information for any existing stimulator.

Our team will contact you to discuss your request and arrange the next step. Your request does not confirm an appointment.

Contact

New patients(609) 831-0998
Existing patients(732) 784-6072
Doctors and referrals(732) 800-5762

Spinal Cord Stimulation FAQ

Who may be a candidate for spinal cord stimulation?
Possible candidates include selected patients with persistent nerve-related pain after back surgery, chronic back or leg pain when additional surgery is not appropriate, painful diabetic neuropathy after inadequate treatment response, or selected CRPS cases. Candidacy depends on diagnosis, neurologic findings, imaging, medical history, goals, and trial response.
Why is there a trial before a permanent implant?
The trial is a temporary test period. Before permanent implantation is considered, you and your care team define practical goals, such as pain reduction, walking tolerance, sleep, activity, or medication reduction when appropriate. A good trial does not guarantee long-term benefit, but it helps guide the decision.
Can I get an MRI with a spinal cord stimulator?
It depends on the exact device, leads, implant location, scanner, and manufacturer conditions. Many modern systems have MRI-conditional labeling, but compatibility must be verified before any scan. Always tell imaging centers you have an implanted stimulator.
What if I already have a stimulator and it is not working well?
Bring the device card, manufacturer, model, implant records if available, and a description of what changed. Some issues may involve programming, charging, lead position, battery status, progression of another condition, or the need to reconsider the diagnosis.
What are the risks?
Risks can include infection, bleeding, pain at the implant site, lead movement or breakage, hardware problems, loss of benefit over time, need for revision or removal, and rare neurological injury. Your individual risk depends on medical history, anatomy, medications, and the planned procedure.
Does SCS treat diabetes, compression, weakness, or instability?
No. SCS modulates pain signaling; it does not treat diabetes itself, decompress nerves, correct instability, or reverse progressive neurologic weakness. Those problems require separate evaluation and treatment planning.

Further patient information: Johns Hopkins Medicine

Your next step

Find out whether SCS fits your situation.

Request a telehealth or in-person evaluation to review your pain, previous treatment and options.

The team will contact you to discuss your request. No outcome is guaranteed.

Contact Apteum

Choose the appropriate line for your inquiry.

New patients / Jessie · (609) 831-0998Existing patients · (732) 784-6072Doctors / referrals · (732) 800-5762Intake coordinator · (201) 819-0484

For medical emergencies, call 911.

Scroll to Top